RecruitingPhase 2NCT06490757

A Phase 2 Open-label Single-arm Trial of JAK1 Inhibitor for the Treatment of Large Inflammatory Hepatocellular Adenomas

Studying Hepatocellular adenoma

Last synced from ClinicalTrials.gov May 10, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Assistance Publique - Hôpitaux de Paris
Principal Investigator: Jean-Charles NAULT, PUPH
Assistance Publique des Hôpitaux de Paris (APHP)
Intervention: Baricitinib(drug)
Enrollment: 25 enrolled
Eligibility: 18-65 years · All sexes
Timeline: 2024 – 2028

Study locations (1)

NAULT, Bobigny, France

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06490757 on ClinicalTrials.gov

← Back to all trials